Table 2.
Medication during transplantation and clinical outcomes in recipients. Dex: group administrated with dexmedetomidine; Con: control group received saline. Data are given as the median (SD) or n. ∗P < 0.05 compared between two groups.
| Dex | Con | P value | |
|---|---|---|---|
| Dopamine | 5 | 4 | 1.000 |
| Noradrenaline | 2 | 3 | 0.672 |
| Nitroglycerin | 3 | 4 | 0.708 |
| Atropine | 8 | 1 | 0.027∗ |
| Propofol (mg) | 244.24 (41.157) | 239.38 (27.701) | 0.070 |
| Sevoflurane end tidal concentration | 1.41 (0.252) | 1.39 (0.208) | 0.415 |
| Sufentanil (ug) | 39.24 (4.169) | 41.09 (2.763) | 0.039∗ |
| Remifentanil (ug) | 212.12 (46.284) | 207.19 (35.942) | 0.146 |
| Delayed graft function [n (%)] | 5 (12.8%) | 7 (17.9%) | 0.755 |
| Graft loss [n (%)] | 1 (2.56%) | 0 | 1.000 |
| Primary graft nonfunction [n (%)] | 0 | 0 | — |
| Hospital stay (d) | 21.74 (4.417) | 24.44 (4.778) | 0.012∗ |
| Mortality | 0 | 0 | — |